Safety, Tolerability, and Pharmacokinetics of Liposomal Amphotericin B in Immunocompromised Pediatric Patients.
第一作者:
Nita L,Seibel
第一单位:
Children's National Medical Center and George Washington University School of Medicine and Public Health, Washington, DC, USA.;Clinical Investigations Branch, Cancer Treatment Evaluation Program, National Cancer Institute, Bethesda, Maryland, USA.
作者:
医学主题词
两性霉素B(Amphotericin B);抗真菌药(Antifungal Agents);儿童(Child);儿童, 学龄前(Child, Preschool);肌酸酐(Creatinine);女(雌)性(Female);人类(Humans);免疫减弱宿主(Immunocompromised Host);输注, 静脉内(Infusions, Intravenous);男(雄)性(Male);中性粒细胞减少(Neutropenia);治疗结果(Treatment Outcome);呕吐(Vomiting)
DOI
10.1128/AAC.01477-16
PMID
27855062
发布时间
2018-11-13
- 浏览2
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



